Ivacaftor/tezacaftor

Red

Brand Name(s):Symkevi

Indication:Cystic fibrosis

Rationale:1,2

Considered:Nov-18

Review Date:Apr-26

Comments:
NHS England has confirmed that ivacaftor, tezacaftor/ivacaftor and elexacaftor/tezacaftor/ivacaftor will be made available as treatment options for people with cystic fibrosis who have one of an expanded range of CFTR mutations within the set criteria.
NHS England commissioning statement.
March ’21.